• BioXpress Therapeutics SA

    VS
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-660.6.046.008-3
    Sector: Production of pharmaceutical substances

    Age of the company

    17 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    157'853

    Employees

    PremiumPremium

    Active brands

    0

    Reports for BioXpress Therapeutics SA

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About BioXpress Therapeutics SA

    • BioXpress Therapeutics SA with its legal headquarters in Monthey is active. BioXpress Therapeutics SA operates in the sector «Production of pharmaceutical substances».
    • The management consists of 3 persons. The company was founded on 19.05.2008.
    • On the 11.04.2025 the commercial register entry of the company was last changed. Under «Notifications» you will find all changes.
    • The Enterprise Identification Number of the company BioXpress Therapeutics SA is the following: CHE-114.306.724.
    • Companies with the same address as BioXpress Therapeutics SA: AlphaOnco Swiss SA, BioArk SA, Bionactis International Group (BIG) SA.

    Commercial register information

    Source: SOGC

    Sector

    Production of pharmaceutical substances

    Purpose (Original language)

    Études, recherches, développements, fabrications, procédés de fabrications et commercialisations de produits biologiques ou analogues et tous services dans le domaine scientifique et industriel y relatif; exploitation de toutes marques, formules et brevets relatifs aux domaines susmentionnés.

    Customise the company purpose with just a few clicks.

    Auditor

    Source: SOGC

    Current auditor (1)
    Name City Since Until
    Cofigen SA
    Genève 25.07.2011

    Would you like to adjust the auditors? Click here.

    Former auditor (1)
    Name City Since Until
    FIDUCIAIRE CHAVAZ SA
    Carouge (GE) 23.05.2008 27.08.2009

    Other company names

    Source: SOGC

    Es sind keine früheren oder übersetzten Firmannamen vorhanden.

    Would you like to update the company name? Click here.

    Branches (0)

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: BioXpress Therapeutics SA

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 250411/2025 - 11.04.2025
    Categories: Change of company address

    Publication number: HR02-1006307731, Commercial Registry Office Geneva, (660)

    BioXpress Therapeutics SA, à Genève, CHE-114.306.724 (FOSC du 25.03.2025, p. 0/1006291419). Par suite du transfert de son siège à Monthey, la société est inscrite au Registre du Commerce du Bas-Valais;
    par conséquent, elle est radiée d'office du registre de Genève.

    SOGC 250411/2025 - 11.04.2025
    Categories: Change of company address, Change in management, Change of auditors

    Publication number: HR02-1006307581, Commercial Registry Office Valais, (621)

    BioXpress Therapeutics SA, précédemment à Genève, CHE-114.306.724, société anonyme (No. FOSC 58 du 25.03.2025, Publ. 1006291419).

    Modification des statuts:
    27.03.2025.

    Nouveau siège:
    Monthey.

    Nouvelle adresse:
    c/o BioArk SA, Route de l'Ile-au-Bois 1a, 1870 Monthey.

    Inscription ou modification de personne(s):
    Hagens, Gerrit, de Langenthal, à Vétroz, administrateur, avec signature collective à deux [précédemment: à Saint-Maurice];
    Cofigen SA (CHE-103.921.167), à Genève, organe de révision [précédemment: Cofigen SA (CH-660-0332987-3)].

    SOGC 250325/2025 - 25.03.2025
    Categories: Change in capital

    Publication number: HR02-1006291419, Commercial Registry Office Geneva, (660)

    BioXpress Therapeutics SA, à Genève, CHE-114.306.724 (FOSC du 07.02.2025, p. 0/1006251397). Augmentation du capital-actions au moyen d'un capital conditionnel, porté de CHF 155'853 à CHF 157'853 par l'émission de 2'000 actions de CHF 1, nominatives, liées selon statuts.

    Capital-actions:
    CHF 157'853, entièrement libéré, divisé en 157'853 actions de CHF 1, nominatives, liées selon statuts. Statuts modifiés le 13.03.2025.

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm